Legal Representation
Attorney
Scott D. Woldow
USPTO Deadlines
Application History
45 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 8, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Apr 8, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Aug 9, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 8, 2023 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Aug 1, 2023 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Aug 8, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Aug 1, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 4, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 2, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Feb 2, 2023 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Feb 2, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 4, 2023 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Aug 4, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 2, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Aug 2, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 2, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 4, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 2, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Feb 2, 2022 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Feb 2, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 30, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 28, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 28, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 28, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 2, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 5, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 5, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 16, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 1, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 13, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 13, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 2, 2020 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Jun 23, 2020 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jun 23, 2020 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Jun 23, 2020 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Jun 5, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 5, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 3, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 26, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 26, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 26, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 26, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 19, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 4, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 22, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Cell lines for scientific and research use; Cells for scientific, laboratory or medical research; Biological preparations, namely, viral vectors and gene vectors for scientific, laboratory or medical research
Class 005
Cell lines for medical purposes; Cells for medical or clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating cancer, tumors, genetic diseases, immunodeficiency conditions, stem cell transplantation, and transplant medicine; Cell lines for medical purposes, namely, cell therapy; Cell lines for medical purposes, namely, immunotherapy; Cell lines for medical purposes, namely, for use as therapeutics to repair, replace or preserve cells and tissues; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating genetically engineered tissues and for treating transplant conditions; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating viral and infectious diseases; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders
Classification
International Classes
001
005